Investors in Bristol-Myers Squibb can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the American market. Analysts expect a dividend of 1,62 USD per share. Thus the dividend yield equals 3,2 percent. The average dividend yield of the pharmaceutical companies is a moderate 0,5 percent.
Tomorrow Bristol-Myers Squibb will publish its past quarter's results. For this year Bristol-Myers Squibb 's revenue will be around 22,4 billion USD. This is according to the average of the analysts' estimates. This is slightly more than 2017's revenue of 20,78 billion USD.
The analysts expect for 2018 a net profit of 5,95 billion USD. The majority of the analysts expects for this year a profit per share of 3,64 USD. The price-earnings-ratio equals 13,91.
Bristol-Myers Squibb 's market capitalization is based on the number of outstanding shares around 84,28 billion USD. The Bristol-Myers Squibb stock was the past 12 months quite unstable. Since last October the stock is 18 percent lower. This year the stock price moved between 50 and 70 dollar. Since 2008 the stock price is almost 187 percent higher.
On Tuesday the stock closed at 50,65 USD.ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.